Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShort-Term Debt repayments
Ratios

Gain Therapeutics (GANX) Receivables - Net (2020 - 2025)

Gain Therapeutics (GANX) has 3 years of Receivables - Net data on record, last reported at $400000.0 in Q3 2025.

  • For Q3 2025, Receivables - Net changed N/A year-over-year to $400000.0; the TTM value through Sep 2025 reached $400000.0, changed N/A, while the annual FY2021 figure was $81862.0, 857.67% up from the prior year.
  • Receivables - Net reached $400000.0 in Q3 2025 per GANX's latest filing, roughly flat from $400000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $400000.0 in Q2 2025 and bottomed at $4486.0 in Q1 2021.